What is the current athrectomy devices market size?

The athrectomy devices market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the athrectomy devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the athrectomy devices market?

Increasing demand for minimally invasive procedures drives the market.

What are the major challenges facing the athrectomy devices market?

High costs and limited reimbursement options are significant challenges.

Which regions are leading the athrectomy devices market?

North America and Europe are the leading regions.

Who are the top companies in the athrectomy devices market?

Top companies include Medtronic and Boston Scientific.

What future opportunities exist in the athrectomy devices market?

Emerging markets and technological advancements offer opportunities.

How will technology impact the future outlook of the athrectomy devices market?

Advances in robotics and artificial intelligence will significantly impact the market.

What is the current regulatory landscape for the athrectomy devices market?

Stringent regulations and approvals are required for market entry.

How will the athrectomy devices market size change in the future?

The market size is expected to increase due to growing demand.

What Is the Global athrectomy devices Market Worth in 2026?

athrectomy devices by Application (Cardiovascular, Peripheral, Neurovascular), by Types (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

athrectomy devices Market Size | CAGR 7.2 Forecast 2033

What Is the Global athrectomy devices Market Worth in 2026?

athrectomy devices by Application (Cardiovascular, Peripheral, Neurovascular), by Types (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

athrectomy devices Market Overview

The athrectomy devices market refers to the industry that provides medical devices used to remove plaque and other blockages from arteries. As the global population ages and the prevalence of cardiovascular diseases increases, the relevance of this market grows. The athrectomy devices market size is estimated to be around $1.3 billion in 2025, with a growth outlook that is expected to be driven by advancements in technology and an increasing demand for minimally invasive procedures. The market forecast indicates a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033, with the global industry expansion expected to be fueled by the rising incidence of cardiovascular diseases and the growing need for effective treatment options.

Loading chart…

The athrectomy devices market is expected to be shaped by several key forces, including technology shifts towards more minimally invasive procedures, regulatory changes that impact the approval and adoption of new devices, and consumer behavior that prioritizes effective and safe treatment options. The largest region for the athrectomy devices market is North America, while the fastest-growing region is expected to be Asia-Pacific. Overall, the athrectomy devices market is poised for significant growth and expansion over the next several years, driven by the increasing demand for effective and minimally invasive treatment options for cardiovascular diseases.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Boston Scientific; Cardiovascular Systems; Medtronic; Spectranetics; VOLCANO; Avinger; Bayer; Straub Medical; Abbott; BARD Peripheral Vascular; Cardinal Health (Cordis); Terumo
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The athrectomy devices market is poised for significant growth, driven by various factors that are shaping its dynamics. Understanding these market dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in athrectomy devices technology, such as the development of more precise and minimally invasive procedures, are expected to drive the athrectomy devices market size and contribute to its growth forecast.

Increasing prevalence of cardiovascular diseases and the growing need for effective treatment options are fueling the demand for athrectomy devices, thereby driving market growth.

Restraints2 items

High costs associated with athrectomy devices and procedures may limit their adoption in price-sensitive markets, acting as a restraint on the athrectomy devices market size.

Stringent regulatory frameworks and the need for compliance with safety and efficacy standards may hinder the pace of innovation and growth forecast in the athrectomy devices market.

Opportunities2 items

Emerging markets present significant opportunities for the athrectomy devices market, driven by increasing healthcare expenditure, improving infrastructure, and a rising awareness of cardiovascular diseases.

The development of athrectomy devices with advanced features, such as real-time imaging and navigation, offers opportunities for market players to differentiate their products and gain a competitive edge.

Challenges2 items

The athrectomy devices market faces challenges related to reimbursement and insurance coverage, as the high costs of procedures and devices may not be fully covered, affecting patient access and market growth.

Ensuring the long-term efficacy and safety of athrectomy devices remains a challenge, requiring ongoing clinical trials and post-market surveillance to maintain regulatory compliance and patient trust.

Market Segmentation

Loading chart…

The application segment of the athrectomy devices market is a crucial aspect of athrectomy devices segmentation, as it defines the specific use cases for these devices. This segment is divided into subcategories, including cardiovascular, neurology, and peripheral vascular applications. Each of these subcategories contributes to the overall athrectomy devices market size, with cardiovascular applications being the most prominent due to the high prevalence of cardiovascular diseases globally.

The types segment of the athrectomy devices market is another significant aspect, comprising subtypes such as directional atherectomy, rotational atherectomy, and orbital atherectomy. Each subtype has its unique features and applications, contributing to the overall market size. Directional atherectomy, for instance, is widely used for treating peripheral artery disease, while rotational atherectomy is often used for treating complex coronary artery lesions. Understanding these subtypes is essential for market taxonomy and analyzing the competitive landscape of the athrectomy devices market.

athrectomy devices Segmentation Breakdown9 items

Application

Cardiovascular

Peripheral

Neurovascular

Types

Directional Atherectomy

Rotational Atherectomy

Orbital Atherectomy

Laser Atherectomy

Regional Insights

Loading chart…

The athrectomy devices market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share, driven by factors such as high adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure. The Asia Pacific region is expected to be the fastest-growing region, driven by increasing demographics, improving infrastructure, and growing ecosystem maturity.

Key drivers for each region include: for North America, high adoption of minimally invasive procedures, favorable reimbursement policies, and significant investments in research and development. For Europe, growing demand for athrectomy devices, stringent regulatory frameworks, and increasing competition among market players. For Asia Pacific, rapidly growing demographics, improving healthcare infrastructure, and increasing awareness of athrectomy devices. For Latin America, growing healthcare expenditure, increasing adoption of advanced medical technologies, and improving economic conditions. For Middle East & Africa, growing demand for athrectomy devices, increasing investments in healthcare infrastructure, and improving regulatory frameworks.

The regional forecast indicates that the athrectomy devices market will continue to grow, driven by increasing demand for minimally invasive procedures, advancements in medical technology, and growing awareness of athrectomy devices. As the market continues to evolve, it is essential to monitor regional trends and market dynamics to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The athrectomy devices market is moderately consolidated, with a mix of global players and local companies competing for market share. The athrectomy devices competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their distribution networks and investing in product innovation to stay ahead of local companies.

Companies in the market are adopting various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and expansion into new regions. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To mitigate these risks, companies are focusing on developing unique technologies, strengthening their service models, and building strong channel partnerships.

Boston Scientific: regional expansion

Cardiovascular Systems: innovation pipeline

Medtronic: premium pricing

Spectranetics: OEM tie-ups

VOLCANO: local manufacturing

Avinger: vertical integration

Key athrectomy devices Companies12 items

Boston Scientific

Cardiovascular Systems

Medtronic

Spectranetics

VOLCANO

Avinger

Bayer

Straub Medical

Abbott

BARD Peripheral Vascular

Cardinal Health (Cordis)

Terumo

Market Ecosystem

The athrectomy devices ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured as raw materials and components are transformed into finished products, which are then distributed and sold to end users. The athrectomy devices ecosystem is characterized by a complex web of interactions among various participants, influencing the development, production, and adoption of these devices.

Raw material/component suppliers — providing critical components

OEMs / manufacturers — designing and producing athrectomy devices

Technology providers — developing underlying technologies

System integrators / EPCs — integrating devices into healthcare systems

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — setting industry standards and regulations

End users / buyers — purchasing and utilizing athrectomy devices

In the athrectomy devices ecosystem, value flows through the interactions among these participants, with control points influencing adoption, such as regulatory approvals and industry standards. Dependency risks, including input constraints and approvals, can impact the ecosystem's functioning. Switching costs, partnerships, and interoperability requirements also affect the dynamics of the ecosystem. A thorough value chain analysis is essential to understand the intricacies of the athrectomy devices ecosystem and its regional variations.

Recent Industry Insights

The athrectomy devices industry trends have witnessed significant developments over the last 12-18 months, shaping the future of the market. Recent partnerships between key players have focused on enhancing product portfolios and expanding geographical reach. Notable mergers and acquisitions have also been observed, with companies aiming to consolidate their positions and improve competitiveness.

Furthermore, the launch of innovative product lines and technologies has been a major highlight, offering improved treatment outcomes and patient experiences. Regulatory changes have also played a crucial role, with updated guidelines and approvals influencing the adoption of athrectomy devices. A shift in consumer preferences towards minimally invasive procedures has driven demand for advanced athrectomy devices, while funding rounds and expansions have supported the growth of companies in this space.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the athrectomy devices market. The market attractiveness is moderate, driven by increasing demand for minimally invasive procedures. The competitive intensity is high, with key players investing heavily in research and development. The long-term athrectomy devices market outlook is promising, with advancements in technology and innovation expected to drive growth. However, the demand-supply balance is a concern, with potential risks including regulatory challenges and supply chain disruptions. Key risk factors include intense competition and rapid technological changes, which may impact market players' ability to adapt and innovate.

11 items

1. Executive Summary

2. athrectomy devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global athrectomy devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global athrectomy devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cardiovascular

6.1.2. Peripheral

6.1.3. Neurovascular

6.2. Global athrectomy devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Directional Atherectomy

6.2.2. Rotational Atherectomy

6.2.3. Orbital Atherectomy

6.2.4. Laser Atherectomy

6.3. Global athrectomy devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global athrectomy devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global athrectomy devices Market by: Regions (Value)

8. Global athrectomy devices Market Competition by Key Manufacturers

8.1. Global athrectomy devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global athrectomy devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boston Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cardiovascular Systems

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Medtronic

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Spectranetics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. VOLCANO

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Avinger

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Bayer

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Straub Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Abbott

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BARD Peripheral Vascular

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Cardinal Health (Cordis)

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Terumo

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global athrectomy devices Market

Figure 4: Global athrectomy devices Market: Drivers

Figure 5: Global athrectomy devices Market: Challenges

Figure 6: Global athrectomy devices Market: Trends

Figure 7: Global athrectomy devices Market: Opportunity

Figure 8: Global athrectomy devices Market: Restraint

Figure 9: Global athrectomy devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global athrectomy devices Market Value (USD Million) By Region

Figure 15: Global athrectomy devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global athrectomy devices Market Value (USD Million) By Region

Figure 23: Global athrectomy devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global athrectomy devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global athrectomy devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global athrectomy devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global athrectomy devices Market Value (USD Million) By Region

Table 10: Global athrectomy devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global athrectomy devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global athrectomy devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global athrectomy devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boston Scientific Basic Information And Sales Area

Table 31: Boston Scientific. Products Portfolio

Table 32: Cardiovascular Systems Basic Information And Sales Area

Table 33: Cardiovascular Systems. Products Portfolio

Table 34: Medtronic Basic Information And Sales Area

Table 35: Medtronic. Products Portfolio

Table 36: Spectranetics Basic Information And Sales Area

Table 37: Spectranetics. Products Portfolio

Table 38: VOLCANO Basic Information And Sales Area

Table 39: VOLCANO. Products Portfolio

Table 40: Avinger Basic Information And Sales Area

Table 41: Avinger. Products Portfolio

Table 42: Bayer Basic Information And Sales Area

Table 43: Bayer. Products Portfolio

Table 44: Straub Medical Basic Information And Sales Area

Table 45: Straub Medical. Products Portfolio

Table 46: Abbott Basic Information And Sales Area

Table 47: Abbott. Products Portfolio

Table 48: BARD Peripheral Vascular Basic Information And Sales Area

Table 49: BARD Peripheral Vascular. Products Portfolio

Table 50: Cardinal Health (Cordis) Basic Information And Sales Area

Table 51: Cardinal Health (Cordis). Products Portfolio

Table 52: Terumo Basic Information And Sales Area

Table 53: Terumo. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global athrectomy devices Market Value (USD Million) By Region

Table 59: Global athrectomy devices Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

athrectomy devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Boston Scientific; Cardiovascular Systems; Medtronic; Spectranetics; VOLCANO; Avinger; Bayer; Straub Medical; Abbott; BARD Peripheral Vascular; Cardinal Health (Cordis); Terumo
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options